Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peter Krengel
Institution:
Bristol-Myers Squibb (United States)
Observed institution:
Bristol-Myers Squibb (United States)
OpenAlex ID:
A5115022577
Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM
2026
·
Surbhi Sidana
, Yi Lin
, et al.
·
Blood Advances
·
2
PDF
Global Manufacturing Experience with Idecabtagene Vicleucel in Patients with Relapsed and Refractory Multiple Myeloma
2024
·
Surbhi Sidana
, Christof Scheid
, et al.
·
Blood
·
1
Show more works
View as search
Works count:
2
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type
